Source link : https://www.newshealth.biz/health-news/fda-approves-first-novel-drug-for-schizophrenia-in-decades/
The FDA on Thursday approved xanomeline and trospium chloride (Cobenfy) for schizophrenia in adults, the first new class of drug for the condition in more than 30 years. In contrast to antipsychotics that work on dopaminergic and serotonergic receptors in the brain, the oral agent targets the M1 and M4 muscarinic receptors instead. The novel […]
Author : News Health
Publish date : 2024-09-27 13:31:57
Copyright for syndicated content belongs to the linked Source.